ZA976163B - Pharmaceutical formulations for topical use containing a carbazolyl-(4)-oxy-propanolamine derivative as the active substance - Google Patents

Pharmaceutical formulations for topical use containing a carbazolyl-(4)-oxy-propanolamine derivative as the active substance

Info

Publication number
ZA976163B
ZA976163B ZA976163A ZA976163A ZA976163B ZA 976163 B ZA976163 B ZA 976163B ZA 976163 A ZA976163 A ZA 976163A ZA 976163 A ZA976163 A ZA 976163A ZA 976163 B ZA976163 B ZA 976163B
Authority
ZA
South Africa
Prior art keywords
carbazolyl
oxy
active substance
pharmaceutical formulations
topical use
Prior art date
Application number
ZA976163A
Inventor
Hans-Georg Opitz
Gisbert Sponer
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA976163B publication Critical patent/ZA976163B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA976163A 1996-07-13 1997-07-11 Pharmaceutical formulations for topical use containing a carbazolyl-(4)-oxy-propanolamine derivative as the active substance ZA976163B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19628335A DE19628335A1 (en) 1996-07-13 1996-07-13 Use of topical (carbazolyl-oxy)-propanolamine derivatives

Publications (1)

Publication Number Publication Date
ZA976163B true ZA976163B (en) 1999-01-11

Family

ID=7799774

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976163A ZA976163B (en) 1996-07-13 1997-07-11 Pharmaceutical formulations for topical use containing a carbazolyl-(4)-oxy-propanolamine derivative as the active substance

Country Status (2)

Country Link
DE (1) DE19628335A1 (en)
ZA (1) ZA976163B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (en) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS

Also Published As

Publication number Publication date
DE19628335A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
IL116460A0 (en) Aerosol drug formulations
ZA953236B (en) Pharmaceutical formulations
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
ZA951781B (en) Pharmaceutical formulations
NZ292995A (en) Organic phosphate surfactants; use in pharmaceutical aerosol formulations
HUP9700709A3 (en) 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds
HK1001860A1 (en) I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ZA9510433B (en) Parasiticide formulations suitable for dermal application
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
IL116910A0 (en) Novel pharmaceutical formulation for topical administration
GB9201639D0 (en) Pharmaceutical formulations
ZA976163B (en) Pharmaceutical formulations for topical use containing a carbazolyl-(4)-oxy-propanolamine derivative as the active substance
AU3542697A (en) Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate
GB9413542D0 (en) Pharmaceutical formulations
GB9418550D0 (en) Drug formulation
ZA9510754B (en) Aerosol drug formulations
GB9426113D0 (en) Pharmaceutical formulations
GB9414216D0 (en) Pharmaceutical formulations
GB9408151D0 (en) Pharmaceutical formulations
GB9408162D0 (en) Pharmaceutical formulations
GB9417953D0 (en) Pharmaceutical formulations